Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

Trial II 

CMF + prednisone combined with or without oophorectomy for pre/perimenopausal patients with breast cancer and 4 or more positive nodes.

DESIGN

Design Trial II

Results & Publications


Presentations


Publications

Study Chair
Prof. Aron Goldhirsch - Milano, Italy

Statistician

Karen Price

Trial Coordinators
Holly Shaw

Data Managers
Tara Scolese, Dawn Weinbaum

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 836 6097

Email: ibcsgI-IV@fstrf.org

Date of Activation
July 1, 1978

Date of Closure
September 1, 1981

Final Accrual
1713 patients (1601 evaluable patients)


Results Publications Results & Publications


News

11.07.2014:
New publications are available  

01.06.2014:
New treatment option for young women with hormone‐sensitive breast cancer.

01.06.2014:
ASCO 2014: IBCSG plenary session on TEXT & SOFT trial results.

All News

 
  Print